Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
Date:11/6/2012

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reported financial results for the third quarter ended September 30, 2012.

Arena is preparing for the launch of BELVIQ® (lorcaserin HCl) in the United States, pursuing regulatory approval and collaborations for BELVIQ in additional territories, and selectively advancing its earlier-stage drug candidates. Arena's expected upcoming milestones include the following:

  • Eisai Inc. beginning to market BELVIQ in the United States in early 2013, subject to the US Drug Enforcement Administration's final scheduling designation;
  • Regulatory authorities for the European Union and Switzerland providing their decisions on the Marketing Authorization Applications (MAA) for BELVIQ in the first half of 2013; and
  • Results from the Phase 1 multiple-dose clinical trial of APD811, its internally discovered oral drug candidate for the treatment of pulmonary arterial hypertension (PAH), in the first quarter of 2013.
  • "We are well positioned to deliver significant value to our stockholders by executing on the potential of BELVIQ and strategically advancing our pipeline of internally discovered drug candidates," said Jack Lief, Arena's President and Chief Executive Officer. "We look forward to providing a novel treatment option to patients who need help with chronic weight management. As we prepare for the US launch of BELVIQ, we continue to pursue additional regulatory approvals and collaborations in strategic markets worldwide."

    Recent Developments

  • Established a marketing and supply agreement between its wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Ildong Pharmaceutical Co., Ltd., for BELVIQ. Under the agreement, Arena granted Ildong exclusive rights to market and distribute BELVIQ in South Korea for we
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6
    2. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    3. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
    4. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
    5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    6. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    7. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    8. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    9. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    10. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    11. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... , May 5, 2015  Astellas announced that two ... one abstract detailing clinical data from a study of ... presented during a late breaking plenary session at the ... on May 17 in New Orleans, Louisiana ... Phase 2 studies designed to evaluate enzalutamide compared to ...
    (Date:5/5/2015)... MINNEAPOLIS , May 5, 2015 Bio-Techne ... of Directors has decided to pay a dividend of ... 2015. The quarterly dividend will be payable May 29, ... 15, 2015.  Future cash dividends will be considered by ... Bio-Techne Corporation (NASDAQ: TECH ) is a ...
    (Date:5/5/2015)... -- - No one has covered cath ... ABMRG - Primary research covering 700 angioplasty ... among states & regions; hospital chains; govt. & pvt. ... coronary stent market in India , ... (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 ...
    Breaking Medicine Technology:Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 2Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 3Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 4Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 5Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 6Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 7Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 8Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 9India Coronary Stent Market to be Tripled by 2021 2India Coronary Stent Market to be Tripled by 2021 3India Coronary Stent Market to be Tripled by 2021 4
    ... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... on Tuesday, May 8, 2012 at 4:30 p.m. EDT/9:30 p.m. ... and financial update and review first quarter 2012 results. ... from the Investors section of the Jazz Pharmaceuticals website at ...
    ... IRVINE, Calif., April 30, 2012  PRO-DEX, INC. (Nasdaq: ... in management,s broadcast review of the Company,s fiscal 2012 ... ) The conference call is scheduled ... May 4, 2012 at 4:30 p.m. Eastern Time (1:30 ...
    Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast 2
    (Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch as ... small, medium, and large businesses making an impact in their ... expert, conducted the business review and shared with viewers how ... weeks of vacation for free. , Vacations are a sought-after ... world. And when people are preparing for vacations, they’re used ...
    (Date:5/5/2015)... This year, PolyU researchers garnered two ... Awards, three Gold Medals and four Silver Medals at ... follows: , (1) Grand Prize and Gold Medal with ... Design and Fitting, Principal Investigator: Dr Allan Chee-kooi CHAN, ... relies very much on the “mannequin” for many tasks ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 ... mission-focused company serving the federal government, today announced ... (CCSi). CCSi provides solutions exclusively to federal ... extensive experience in cyber security, health services, and ... processes and industry-relevant credentials as a Third Party ...
    (Date:5/5/2015)... The brains of people with type ... with slower information processing, according to research led by ... Health . , The findings indicate that clinicians ... for cognitive difficulties. If progressive, these changes could influence ... by the National Institutes of Health (NIH), ...
    (Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
    Breaking Medicine News(10 mins):Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2
    ... New research released to mark No Smoking Day (11 March) ... in Great Britain are thinking,about or planning to cut down or ... shows that one in ten (9%) will be taking the first,step ... No Smoking Day President and Dragons, Den star, ...
    ... , , TUESDAY, March 10 (HealthDay News) -- Used together, a ... in detecting ovarian cancer in its early and more curable ... become a new standard in the fight against this deadly ... to be an approach that may be workable," said Robert ...
    ... state budget maintains charity care spending levelMARLTON, N.J., March ... Virtua Health, praised New Jersey Governor Jon Corzine, Health ... for placing a high priority on the health care ... that was unveiled today in Trenton.In the state fiscal ...
    ... ARBOR, Mich.---Biomedical and materials engineers at the University ... brain implants that helps the devices operate longer ... epilepsy and Parkinson,s disease. , Currently, brain implants ... and the next generation of the devices operate ...
    ... A recent CBS 60 Minutes TV program drew ... molecule believed to largely be responsible for the ... more people living beyond 100 years and exhibit ... than other people living in other developed countries, ...
    ... people with peripheral arterial disease, study finds, , , ... arterial disease with drug-eluting stents may save lives ... Greek researchers have found. , Peripheral arterial disease ... leads to severe obstructions, known as critical limb ...
    Cached Medicine News:Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 3Health News:Combo of Tests Might Spot Ovarian Cancer Early 2Health News:Combo of Tests Might Spot Ovarian Cancer Early 3Health News:Virtua Commends Gov. Corzine's Charity Care Funding Plan 2Health News:Nanotech coating could lead to better brain implants to treat diseases 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Drug-Eluting Stents Show Promise for Leg Arteries 2Health News:Drug-Eluting Stents Show Promise for Leg Arteries 3
    The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
    Classic proven design with superior clinical results....
    The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
    Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
    Medicine Products: